Macquarie Group’s Theravance Biopharma TBPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$2.3M Hold
208,783
﹤0.01% 1180
2025
Q1
$1.86M Hold
208,783
﹤0.01% 1245
2024
Q4
$1.97M Hold
208,783
﹤0.01% 1198
2024
Q3
$1.68M Sell
208,783
-709
-0.3% -$5.72K ﹤0.01% 1282
2024
Q2
$1.78M Buy
209,492
+709
+0.3% +$6.01K ﹤0.01% 1265
2024
Q1
$1.87M Hold
208,783
﹤0.01% 1239
2023
Q4
$2.35M Hold
208,783
﹤0.01% 1175
2023
Q3
$1.8M Hold
208,783
﹤0.01% 1193
2023
Q2
$2.16M Hold
208,783
﹤0.01% 1165
2023
Q1
$2.27M Hold
208,783
﹤0.01% 1125
2022
Q4
$2.34M Sell
208,783
-5,296
-2% -$59.4K ﹤0.01% 1166
2022
Q3
$2.18M Sell
214,079
-633
-0.3% -$6.44K ﹤0.01% 1197
2022
Q2
$1.95M Hold
214,712
﹤0.01% 1306
2022
Q1
$2.05K Hold
214,712
﹤0.01% 1363
2021
Q4
$2.37M Hold
214,712
﹤0.01% 1322
2021
Q3
$1.59M Sell
214,712
-75,546
-26% -$559K ﹤0.01% 1454
2021
Q2
$4.22M Buy
290,258
+208,783
+256% +$3.03M ﹤0.01% 1178
2021
Q1
$1.66M Buy
81,475
+11,417
+16% +$233K ﹤0.01% 1256
2020
Q4
$1.25M Buy
70,058
+18,675
+36% +$332K ﹤0.01% 1250
2020
Q3
$760K Sell
51,383
-1,854
-3% -$27.4K ﹤0.01% 1299
2020
Q2
$1.12M Buy
+53,237
New +$1.12M ﹤0.01% 1174
2016
Q1
Sell
-50,000
Closed -$820K 1589
2015
Q4
$820K Hold
50,000
﹤0.01% 1108
2015
Q3
$550K Hold
50,000
﹤0.01% 1229
2015
Q2
$651K Hold
50,000
﹤0.01% 1254
2015
Q1
$868K Sell
50,000
-27,548
-36% -$478K ﹤0.01% 1186
2014
Q4
$1.16M Buy
+77,548
New +$1.16M ﹤0.01% 1137